Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Total Non-Current Liabilities (2019 - 2025)

Historic Total Non-Current Liabilities for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $338.4 million.

  • Beam Therapeutics' Total Non-Current Liabilities fell 971.33% to $338.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $338.4 million, marking a year-over-year decrease of 971.33%. This contributed to the annual value of $364.9 million for FY2024, which is 2329.11% down from last year.
  • As of Q3 2025, Beam Therapeutics' Total Non-Current Liabilities stood at $338.4 million, which was down 971.33% from $337.8 million recorded in Q2 2025.
  • In the past 5 years, Beam Therapeutics' Total Non-Current Liabilities ranged from a high of $616.3 million in Q4 2021 and a low of $234.0 million during Q1 2021
  • In the last 5 years, Beam Therapeutics' Total Non-Current Liabilities had a median value of $443.4 million in 2024 and averaged $446.8 million.
  • In the last 5 years, Beam Therapeutics' Total Non-Current Liabilities soared by 34651.84% in 2021 and then tumbled by 2608.11% in 2024.
  • Beam Therapeutics' Total Non-Current Liabilities (Quarter) stood at $616.3 million in 2021, then decreased by 3.34% to $595.8 million in 2022, then decreased by 20.16% to $475.7 million in 2023, then dropped by 23.29% to $364.9 million in 2024, then decreased by 7.26% to $338.4 million in 2025.
  • Its Total Non-Current Liabilities stands at $338.4 million for Q3 2025, versus $337.8 million for Q2 2025 and $337.4 million for Q1 2025.